Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2023 Filed Dec 13, 2023 01:09 UTC |
Lea Darrell ShaneChief Commercial Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-125488 · tm2332764-3_4seq1.xml · derivative · entry 2 Lea Darrell Shane · CIK 0001958526 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-17 F1 · date: This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day. F2 · derivative.exercise_date: This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023. Read SEC document |
| June 23, 2023 Filed Dec 13, 2023 01:07 UTC |
Kolean Chad JChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 104,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-125486 · tm2332764-2_4seq1.xml · derivative · entry 2 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires 2033-01-17 F1 · date: This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day. F2 · derivative.exercise_date: This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023. Read SEC document |
| June 23, 2023 Filed Dec 13, 2023 01:04 UTC |
Longcor JarrodChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 144,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-125484 · tm2332764-4_4seq1.xml · derivative · entry 2 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2033-01-17 F1 · date: This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day. F2 · derivative.exercise_date: This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023. Read SEC document |
| June 23, 2023 Filed Dec 13, 2023 01:04 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 261,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-125483 · tm2332764-1_4seq1.xml · derivative · entry 2 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,000 Underlying: Common Stock · 261,000 shares Expires 2033-01-17 F1 · date: This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day. F2 · derivative.exercise_date: This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023. Read SEC document |
| February 15, 2023 Filed Mar 16, 2023 22:02 UTC |
Shustov AndreiSenior Vice President, Medical
|
GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001104659-23-033409 · tm239814d2_4.xml · derivative · entry 1 Shustov Andrei · CIK 0001969686 · Senior Vice President, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: This option shall vest in three approximately equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:34 UTC |
Longcor JarrodChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 144,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-004701 · tm233841-3_4seq1.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:34 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 261,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-004700 · tm233841-2_4seq1.xml · derivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,000 Underlying: Common Stock · 261,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:33 UTC |
Kolean Chad JChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 104,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-23-004699 · tm233841-1_4seq1.xml · derivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| November 21, 2022 Filed Dec 15, 2022 22:00 UTC |
Lea Darrell ShaneChief Commercial Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001140361-22-045712 · form4.xml · derivative · entry 1 Lea Darrell Shane · CIK 0001958526 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-21 F1 · derivative.exercise_date: This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date. Read SEC document |
| June 24, 2022 Filed Aug 1, 2022 22:00 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 7,800 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-22-084835 · tm2222253-2_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2032-06-24 F1 · derivative.exercise_price: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F2 · derivative.exercise_date: This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. F1 · derivative.underlying_shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · balance_after: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. Read SEC document |
| June 24, 2022 Filed Aug 1, 2022 22:01 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 7,800 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-22-084838 · tm2222253-4_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2032-06-24 F1 · derivative.exercise_price: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F2 · derivative.exercise_date: This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. F1 · derivative.underlying_shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · balance_after: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. Read SEC document |
| June 24, 2022 Filed Aug 1, 2022 22:00 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 7,800 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-22-084832 · tm2222253-1_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2032-06-24 F1 · derivative.exercise_price: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F2 · derivative.exercise_date: This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. F1 · derivative.underlying_shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · balance_after: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. Read SEC document |
| June 24, 2022 Filed Aug 1, 2022 22:01 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 7,800 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-22-084837 · tm2222253-3_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2032-06-24 F1 · derivative.exercise_price: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F2 · derivative.exercise_date: This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. F1 · derivative.underlying_shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · balance_after: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. Read SEC document |
| June 24, 2022 Filed Aug 1, 2022 22:01 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 11,700 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-22-084839 · tm2222253-5_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Underlying: Common Stock · 11,700 shares Expires 2032-06-24 F1 · derivative.exercise_price: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F2 · derivative.exercise_date: This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. F1 · derivative.underlying_shares: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. F1 · balance_after: Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:00 UTC |
Kolean Chad JChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-22-006594 · form4.xml · derivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:06 UTC |
Longcor JarrodChief Business Officer
|
GrantStock option (right to buy) · Derivative | 475,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001104659-22-008280 · tm224689-3_4seq1.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,000 Underlying: Common Stock · 475,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:06 UTC |
Elefant DovChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 422,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001104659-22-008278 · tm224689-2_4seq1.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,000 Underlying: Common Stock · 422,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:05 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 1,419,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001104659-22-008277 · tm224689-1_4seq1.xml · derivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,000 Underlying: Common Stock · 1,419,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:00 UTC |
Swirsky Douglas JDirector
|
PurchaseCommon Stock | 25,000 | $1.04 | $26,000.00 |
DisclosureSEC source: 0001104659-21-115477 · tm2127646-1_4seq1.xml · nonDerivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 20:01 UTC |
DRISCOLL FREDERICK WDirector
|
PurchaseCommon Stock | 19,417 | $1.04 | $20,244.16 |
DisclosureSEC source: 0001104659-21-113416 · tm2127071-1_4seq1.xml · nonDerivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,417 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:03 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 78,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001104659-21-088836 · tm2120855-3_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: This option shall vest on the first anniversary of the date of grant. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:03 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 78,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001104659-21-088841 · tm2120855-5_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: This option shall vest on the first anniversary of the date of grant. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:02 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 78,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001104659-21-088833 · tm2120855-2_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: Stock option vest in equal annual increments on June 30, 2022, June 30, 2023, and June 30, 2024. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:03 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 78,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001104659-21-088839 · tm2120855-4_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: This option shall vest on the first anniversary of the date of grant. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:04 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 117,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001104659-21-088842 · tm2120855-6_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 Underlying: Common Stock · 117,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: This option shall vest on the first anniversary of the date of grant. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:06 UTC |
NEIS JOHNDirector
|
SaleSeries A Warrants · Derivative | 23,232 | $0.25 Strike: $30.40 | $5,859.11 |
DisclosureSEC source: 0001104659-21-039056 · tm2110277d1_4seq1.xml · derivative · entry 2 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,323 shares Expires 2021-04-20 F2 · derivative.underlying_shares: The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.24 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:06 UTC |
NEIS JOHNDirector
|
SaleSeries A Warrants · Derivative | 58,640 | $0.28 Strike: $30.40 | $16,272.60 |
DisclosureSEC source: 0001104659-21-039056 · tm2110277d1_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,232 Underlying: Common Stock · 5,864 shares Expires 2021-04-20 F1 · derivative.underlying_shares: The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.27 and $0.2845, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 00:54 UTC |
NEIS JOHNDirector
|
SaleSeries A Warrants · Derivative | 100,515 | $0.31 Strike: $30.40 | $31,069.19 |
DisclosureSEC source: 0001104659-21-037323 · tm2110008d1_4.xml · derivative · entry 3 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,872 Underlying: Common Stock · 10,051 shares Expires 2021-04-20 F3 · derivative.underlying_shares: The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.28 and $0.34, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:54 UTC |
NEIS JOHNDirector
|
SaleSeries A Warrants · Derivative | 11,200 | $0.27 Strike: $30.40 | $2,970.24 |
DisclosureSEC source: 0001104659-21-037323 · tm2110008d1_4.xml · derivative · entry 2 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,387 Underlying: Common Stock · 1,120 shares Expires 2021-04-20 F2 · derivative.underlying_shares: The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.265 and $0.2666, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:54 UTC |
NEIS JOHNDirector
|
SaleSeries A Warrants · Derivative | 41,155 | $0.27 Strike: $30.40 | $10,980.15 |
DisclosureSEC source: 0001104659-21-037323 · tm2110008d1_4.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,587 Underlying: Common Stock · 4,115 shares Expires 2021-04-20 F1 · derivative.underlying_shares: The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.2648 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:46 UTC |
Friend John E. IIChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 330,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001104659-21-032851 · tm218888d1_4.xml · derivative · entry 1 Friend John E. II · CIK 0001704021 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2021-03-04 F1 · derivative.exercise_date: This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:46 UTC |
Elefant DovChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 430,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001104659-21-032853 · tm218888d4_4.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 Underlying: Common Stock · 430,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years form the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:46 UTC |
Longcor JarrodChief Business Officer
|
GrantStock option (right to buy) · Derivative | 450,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001104659-21-032852 · tm218888d2_4.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2021-03-04 F1 · derivative.exercise_date: This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:45 UTC |
CARUSO JAMES VDirector · President and CEO
|
SaleSeries A Warrants · Derivative | 46,948 | $0.19 Strike: $30.40 | $8,718.24 |
DisclosureSEC source: 0001104659-21-032850 · tm218888d3_4seq1.xml · derivative · entry 3 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,694 shares Expires 2021-04-20 F2 · derivative.exercise_price: Ten warrants are convertible into one share of Cellectar's common stock at an exercise price of $30.40 per share of common stock. F1 · shares: Mr. Caruso used the proceeds of the sale of the Series A Warrants, which expire in April 2021, to purchase shares of Cellectar's common stock. F2 · derivative.underlying_shares: Ten warrants are convertible into one share of Cellectar's common stock at an exercise price of $30.40 per share of common stock. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:45 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 1,600,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001104659-21-032850 · tm218888d3_4seq1.xml · derivative · entry 2 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common Stock · 1,600,000 shares Expires 2031-03-04 F3 · derivative.exercise_date: This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:45 UTC |
CARUSO JAMES VDirector · President and CEO
|
PurchaseCommon Stock | 5,100 | $1.70 | $8,658.78 |
DisclosureSEC source: 0001104659-21-032850 · tm218888d3_4seq1.xml · nonDerivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,401 F1 · shares: Mr. Caruso used the proceeds of the sale of the Series A Warrants, which expire in April 2021, to purchase shares of Cellectar's common stock. Read SEC document |
| December 28, 2020 Filed Dec 28, 2020 21:30 UTC |
Elefant DovChief Financial Officer
|
PurchaseCommon Stock | 7,407 | $1.35 | $9,999.45 |
DisclosureSEC source: 0001104659-20-139783 · tm2039438d1_4.xml · nonDerivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,755 Read SEC document |
| December 28, 2020 Filed Dec 28, 2020 21:31 UTC |
CARUSO JAMES VDirector · President and CEO
|
PurchaseCommon Stock | 37,037 | $1.35 | $49,999.95 |
DisclosureSEC source: 0001104659-20-139787 · tm2039438d3_4.xml · nonDerivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,301 Read SEC document |
| December 28, 2020 Filed Dec 28, 2020 21:31 UTC |
Longcor JarrodChief Business Officer
|
PurchaseCommon Stock | 29,630 | $1.35 | $40,000.50 |
DisclosureSEC source: 0001104659-20-139786 · tm2039438d2_4.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,148 Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 10:06 UTC |
Friend John E. IIVP, Chief Medical Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001104659-20-080841 · tm2023996d2_4.xml · derivative · entry 1 Friend John E. II · CIK 0001704021 · VP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-01 F1 · derivative.exercise_date: The option shall vest in three equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:21 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-20-076870 · tm2023456d2_4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:23 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-20-076873 · tm2023456d5_4.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:24 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-20-076875 · tm2023456d6_4.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:22 UTC |
HILL STEPHEN ADirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-20-076872 · m2023456d4_4.xml · derivative · entry 1 HILL STEPHEN A · CIK 0001237404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:22 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-20-076871 · tm2023456d3_4.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:08 UTC |
Elefant DovChief Financial Officer
|
PurchaseSeries H Warrants · Derivative | 2,174 | $0.01 Strike: $1.21 | $21.74 |
DisclosureSEC source: 0001104659-20-070840 · tm2022064d3_4.xml · derivative · entry 2 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,174 Underlying: Common Stock · 2,174 shares Expires 2025-06-05 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:08 UTC |
Elefant DovChief Financial Officer
|
PurchaseCommon Stock | 4,348 | $1.15 | $4,978.46 |
DisclosureSEC source: 0001104659-20-070840 · tm2022064d3_4.xml · nonDerivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:08 UTC |
Longcor JarrodChief Business Officer
|
PurchaseSeries H Warrants · Derivative | 32,609 | $0.01 Strike: $1.21 | $326.09 |
DisclosureSEC source: 0001104659-20-070839 · tm2022064d1_4.xml · derivative · entry 2 Longcor Jarrod · CIK 0001545565 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,609 Underlying: Common Stock · 32,609 shares Expires 2025-06-05 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:08 UTC |
Longcor JarrodChief Business Officer
|
PurchaseCommon Stock | 65,218 | $1.15 | $74,674.61 |
DisclosureSEC source: 0001104659-20-070839 · tm2022064d1_4.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,518 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:07 UTC |
CARUSO JAMES VDirector · President and CEO
|
PurchaseSeries H Warrants · Derivative | 10,870 | $0.01 Strike: $1.21 | $108.70 |
DisclosureSEC source: 0001104659-20-070837 · tm2022064d2_4.xml · derivative · entry 2 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,870 Underlying: Common Stock · 10,870 shares Expires 2025-06-05 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.